Jeannie Lee

Oct 1, 2024 | morningstar.com | Jeannie Lee

TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that following its annual general meeting held on September 30, 2024 (the “Meeting”) and in accordance with Titan’s Majority Voting Policy (the “Voting Policy”), Anthony Giovinazzo, Cathy Steiner, Cary Vance and Paul Cataford have tendered to the Board of Directors (the “Board”) their resignations as directors of Titan (including Paul Cataford’s resignation as Board Chairman).

Sep 26, 2024 | morningstar.com | Jeannie Lee

TORONTO, Ontario, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Conavi Medical Inc. (“Conavi”) has received the requisite shareholder approval required to proceed with the proposed combination of Titan and Conavi (the “Amalgamation”) in an all-stock transaction (the “Transaction”). This Transaction will constitute a reverse takeover of Titan.

Sep 25, 2024 | aornjournal.onlinelibrary.wiley.com | Jeannie Lee |Jeffrey E. Henne |Jack Welsh |Jeannie Lee MSN

Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username

Sep 20, 2024 | biorxiv.org | Yongwoo Lee |Roy Blum |Michael Rosenberg |Jeannie Lee

AbstractUsing halo-tagged PRC2 and CLAP methodology, Guo et al. recently came to the conclusion that PRC2 is not an RNA binding protein (RBP). They suggested that previous findings are CLIP artifacts and argue that RNA cannot play a direct role in PRC2 regulation. Here, we perform a re-analysis of the authors raw datasets and come to contrary conclusions. First, CLAP demonstrates significant PRC2 enrichment throughout the transcriptome, including in XIST Repeat A (RepA) motif.

Sep 8, 2024 | markets.financialcontent.com | Jeannie Lee

TORONTO, Ontario, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that Titan management will host a webcast Q&A session on Thursday, September 19, 2024 at 5:00 pm ET in connection with filing and mailing of the management information circular, which was announced by press release issued on September 6, 2024. Titan will provide prepared remarks followed by a Q&A session.